Imatinib Mesylate
Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+…
Medication Brand Names Beginning with ‘I’, Page 35
Imatinib Mesylate
NDC 70771-1394-9. Imatinib Mesylate Tablets, 100 mg. 90 Tablets Rx only. NDC 70771-1395-9. Imatinib Mesylate Tablets, 400 mg. 90 Tablets Rx only. 100 mg 400 mg.
IMATINIB MESYLATE
Imatinib Mesylate Tablets are a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid…
Imatinib Mesylate 400 Mg (Imatinib Mesylate)
Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+…
Imbruvica (Ibrutinib)
IMBRUVICA is a kinase inhibitor indicated for the treatment of adult patients with: Mantle cell lymphoma (MCL) who have received at least one prior therapy (1.1). This indication is…